TuHURA Biosciences, Inc. (NASDAQ: HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced that its research on ...
The DeGregorio Family Foundation with support from the Torrey Coast Foundation has awarded a $750,000 Michael F. Price ...
Toyota continues to keep a fuel cell or two around just to show ... adapted from Tacoma TRD Pro and Lexus RZ components, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback